Full Text View
Tabular View
No Study Results Posted
Related Studies
Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal Diabetic Neuropathy
This study has been completed.
Study NCT00135109   Information provided by UCB, Inc.

First Received on August 23, 2005.   Last Updated on February 22, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Neuropathies
Additional conditions recognized in this trial
Demyelinating Diseases
Nerve Compression Syndromes
Neurologic Manifestations
Neurotoxicity Syndromes
Polyneuropathies
More general conditions related to this trial
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases
Nervous System Diseases
Neuromuscular Diseases
Peripheral Nervous System Diseases
Poisoning
Signs and Symptoms
Substance-Related Disorders
Interventions listed in this trial
SPM 927
Sponsors listed in this trial
UCB, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services